Listed

China Pharma Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2013

Filed with the SEC on Aug 14, 2013 and accepted by EDGAR at Aug 14, 2013, 17:55 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-04-01 to 2013-06-30$8.0mus-gaap:Revenues
Revenue6 months2013-01-01 to 2013-06-30$16.3mus-gaap:Revenues
Cost of revenue3 months2013-04-01 to 2013-06-30$5.8mus-gaap:CostOfRevenue
Cost of revenue6 months2013-01-01 to 2013-06-30$12.0mus-gaap:CostOfRevenue
Gross profit3 months2013-04-01 to 2013-06-30$2.2mus-gaap:GrossProfit
Gross profit6 months2013-01-01 to 2013-06-30$581.2kus-gaap:GrossProfit
Operating income3 months2013-04-01 to 2013-06-30−$4.8mus-gaap:OperatingIncomeLoss
Operating income6 months2013-01-01 to 2013-06-30−$7.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-04-01 to 2013-06-30−$92.0kus-gaap:InterestExpense
Interest expense6 months2013-01-01 to 2013-06-30−$174.5kus-gaap:InterestExpense
Income tax3 months2013-04-01 to 2013-06-30$388.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2013-01-01 to 2013-06-30$657.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-04-01 to 2013-06-30−$4.5mus-gaap:ProfitLoss
Net income6 months2013-01-01 to 2013-06-30−$7.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-04-01 to 2013-06-30−$0.10us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2013-01-01 to 2013-06-30−$0.17us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-04-01 to 2013-06-30−$0.10us-gaap:EarningsPerShareBasic
Basic EPS6 months2013-01-01 to 2013-06-30−$0.17us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-04-01 to 2013-06-3043,579,557 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2013-01-01 to 2013-06-3043,579,557 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2013-01-01 to 2013-06-30$3.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2013-01-01 to 2013-06-30−$49.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-06-30$2.5mus-gaap:Cash
Current assetsAt period end2013-06-30$101.1mus-gaap:AssetsCurrent
Total assetsAt period end2013-06-30$158.9mus-gaap:Assets
Current liabilitiesAt period end2013-06-30$14.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-06-30$14.7mus-gaap:Liabilities
Shareholders' equityAt period end2013-06-30$144.3mus-gaap:StockholdersEquity
Shares outstandingAt period end2013-06-3043,579,557 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001010549-13-000521. Last ingested by Listed: Nov 11, 2026, 00:23 ET. Listed shows no prices and gives no investment advice.